Publication | Closed Access

Optimal dose reduction of FOLFIRINOX for preserving tumour response in advanced pancreatic cancer: Using cumulative relative dose intensity

OncologyOptimal Dose ReductionTumour ResponsePancreatic CancerMedicinePharmacotherapyAdvanced Pancreatic CancerMetronomic ChemotherapyCancer TreatmentPharmacologyRadiation Oncology